###begin article-title 0
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 33 35 33 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 112 114 112 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 42 47 <span type="species:ncbi:9606">human</span>
Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor
###end article-title 0
###begin p 1
###xml 43 45 43 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 68 70 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 239 241 239 241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 326 328 326 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 368 369 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 393 399 390 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 549 555 542 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 565 567 554 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 573 575 562 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 677 679 666 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;5</sup>
###xml 682 684 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 707 709 696 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 752 754 741 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 834 836 823 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 882 884 871 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 975 977 964 966 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1115 1117 1104 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 1247 1253 1236 1238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 1273 1275 1258 1260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1293 1295 1278 1280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 1401 1403 1386 1388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human lung mast cells (HLMC) express the Ca2+-activated K+ channel KCa3.1, which opens following IgE-dependent activation. This hyperpolarises the cell membrane and potentiates both Ca2+ influx and degranulation. In addition, blockade of KCa3.1 profoundly inhibits HLMC migration to a variety of diverse chemotactic stimuli. KCa3.1 activation is attenuated by the beta2adrenoceptor through a Galphas-coupled mechanism independent of cyclic AMP. Adenosine is an important mediator that both attenuates and enhances HLMC mediator release through the Galphas-coupled A2A and A2B adenosine receptors, respectively. We show that at concentrations that inhibit HLMC degranulation (10-5-10-3 M), adenosine closes KCa3.1 both dose-dependently and reversibly. KCa3.1 suppression by adenosine was reversed partially by the selective adenosine A2A receptor antagonist ZM241385 but not by the A2B receptor antagonist MRS1754, and the effects of adenosine were mimicked by the selective A2A receptor agonist CGS21680. Adenosine also opened a depolarising current carried by non-selective cations. As predicted from the role of KCa3.1 in HLMC migration, adenosine abolished HLMC chemotaxis to asthmatic airway smooth muscle-conditioned medium. In summary, the Galphas-coupled adenosine A2A receptor closes KCa3.1, providing a clearly defined mechanism by which adenosine inhibits HLMC migration and degranulation. A2A receptor agonists with channel-modulating function may be useful for the treatment of mast cell-mediated disease.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 269 270 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 486 487 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 489 490 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 607 609 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 687 688 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 782 783 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 806 807 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 836 837 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 838 839 826 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 854 855 842 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1061 1063 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 1086 1088 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 87 92 <span type="species:ncbi:9606">human</span>
Mast cells are bone marrow-derived cells that are present in all organs throughout the human body, both at mucosal surfaces and within connective tissues. Mast cells play a major role in tissue homeostasis, host defence and the pathophysiology of many diverse diseases 1. They are best known for their role in asthma and allergy through the ability of allergen to cross-link allergen-specific IgE bound to the high-affinity IgE receptor (FcepsilonRI) expressed on the mast cell surface 2, 3. FcepsilonRI cross-linking triggers a complex signalling cascade, which culminates in the influx of extracellular Ca2+ and the release of a plethora of autacoid mediators, proteases and cytokines 1. In addition, the mast cell is activated by many non-immunological stimuli such as cytokines 4, Ig free light chains 5, Toll-like receptor ligands 6-8 and proteases 9, which contribute to the activation of mast cells in response to a variety of tissue insults. In many diseases mast cells re-locate to specific compartments within tissue, such as the airway smooth muscle 10 and submucosal glands 11 in asthma. Drugs that target this migration may prove particularly effective in the treatment of mast cell-mediated disease.
###end p 3
###begin p 4
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 257 259 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 271 272 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 282 284 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 305 307 299 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 310 312 304 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 382 384 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 448 449 442 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 475 477 469 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 507 509 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 511 513 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 572 574 566 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 596 598 590 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 636 638 630 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 663 665 657 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 699 701 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 740 742 734 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 884 886 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 192 197 <span type="species:ncbi:9606">human</span>
Ion channels are emerging as interesting targets for the modulation of biological function in both inflammatory and structural non-excitable cells 12, 13. Following FcepsilonRI cross-linking, human lung mast cells (HLMC) open the intermediate conductance Ca2+-activated K+ channel KCa3.1 (also known as IKCa1/KCa4), which hyperpolarises the cell membrane potential to around -45 mV 14. The negative cell membrane potential generated by these open K+ channels enhances HLMC Ca2+ influx and histamine release 14, 15 due to both the favourable electrical driving force for Ca2+ entry and enhanced Ca2+ conductance through store-operated Ca2+ channels that mediate Ca2+ influx following cell activation 16. Also of great interest, blockade of KCa3.1 virtually abolishes HLMC migration to a number of diverse chemotactic stimuli including asthmatic airway smooth muscle-conditioned medium 17.
###end p 4
###begin p 5
###xml 1 3 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 36 37 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 70 72 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 97 103 94 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 189 190 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 287 288 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 314 316 301 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 577 579 564 566 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 585 587 572 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 634 636 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 637 639 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 646 648 633 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 666 669 653 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 700 706 687 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 722 724 705 707 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 733 736 716 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 844 850 827 829 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 856 862 835 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;q</sub>
###xml 872 874 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 877 879 852 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 961 964 936 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1028 1036 1003 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1041 1048 1016 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1095 1103 1070 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1107 1109 1082 1084 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 1208 1210 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 1211 1213 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 1301 1303 1276 1278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1313 1315 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 1389 1392 1364 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1398 1400 1373 1375 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1489 1491 1464 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;5</sup>
###xml 1497 1499 1472 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 1581 1583 1556 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 1585 1587 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 1589 1591 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 1593 1595 1568 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 1620 1623 1595 1598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1629 1631 1604 1606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1641 1643 1616 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1645 1652 1620 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1772 1774 1747 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1881 1888 1856 1863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2021 2023 1996 1998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 528 533 <span type="species:ncbi:9606">human</span>
###xml 1267 1272 <span type="species:ncbi:9606">human</span>
KCa3.1 in HLMC is closed by the beta2-adrenoceptor agonist salbutamol 18. This occurs through a Galphas G protein-coupled mechanism that is independent of cAMP and explains in part how beta2-adrenoceptor stimulation translates into reduced secretion. Whether this is specific to the beta2-adrenoceptor or whether KCa3.1 is modulated by other G protein-coupled receptors (GPCR) is therefore of great interest. Adenosine is a purine nucleoside generated by numerous cell types in response to cell stress and hypoxia. It modulates human mast cell secretion through the adenosine A2A and A2B GPCR and is of particular relevance to asthma 19-21. The A2A receptor signals via adenylate cyclase, involving Galphas coupling, and A2B signals via multiple mechanisms including adenylate cyclase, diacylglycerol and inositol triphosphate, involving both Galphas and Galphaq coupling 22. A2B signalling has additionally been show to be mediated independently of G proteins via PDZ-containing proteins. The effects of adenosine on HLMC both in vitro and in vivo are complex; at relatively low concentrations in vitro (10-6 M), adenosine is said to potentiate IgE-dependent secretion, but the reported effects vary widely 23-27. Because adenosine induces cytokine secretion from a human mast cell line through the A2B receptor 28, it is also thought that potentiation of secretion from HLMC is mediated via the A2B receptor, but this is not proven. In contrast, at higher concentrations of adenosine (10-5 to 10-3 M), there is more consistent dose-dependent and profound inhibition of secretion 23, 24, 27, 29, mediated predominantly via the A2A receptor 30. In vivo, adenosine induces histamine and tryptase release from resident mast cells when delivered as an aerosol to the airways 31 and induces bronchoconstriction in subjects with asthma but not normal subjects. It is thought that these in vivo effects are mediated directly on mast cells, although it remains possible that intermediaries and neural reflexes are also involved 32.
###end p 5
###begin p 6
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 39 45 39 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 58 59 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 114 116 107 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 118 124 111 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 170 172 159 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 232 234 221 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
Since KCa3.1 in HLMC is closed by the Galphas-coupled beta2-adrenoceptor, we hypothesised that activation of the A2A Galphas-coupled adenosine receptor would also close KCa3.1 in these cells. Furthermore, if adenosine was to close KCa3.1, then it should inhibit HLMC chemotaxis. To test this hypothesis, we used the patch-clamp technique to investigate the effects of adenosine on HLMC ion channel function and investigated the effect of adenosine on HLMC migration in response to asthmatic airway smooth muscle-conditioned medium.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
Inhibition of HLMC IgE-dependent histamine release by adenosine
###end title 8
###begin p 9
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;10</sup>
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 96 103 96 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 296 303 296 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1B</xref>
###xml 408 410 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 416 418 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 432 439 432 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1B</xref>
###xml 470 472 470 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 667 669 664 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 700 707 697 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1C</xref>
Adenosine alone had no effect on mast cell histamine release in the dose range 10-10 to 10-3 M (Fig. 1A). In the presence of anti-IgE, no potentiation of IgE-dependent histamine release by adenosine was evident with either maximal (1:1000 anti-IgE) or sub-maximal (1:30 000 anti-IgE) activation (Fig. 1B). However, there was dose-dependent inhibition of IgE-dependent histamine release over the dose range 10-6 to 10-3 M adenosine (Fig. 1B). Half-maximal suppression (IC50) of histamine release occurred at an adenosine concentration of 73.8+/-23.5 muM. This inhibition of histamine release by adenosine was significantly attenuated in the presence of the adenosine A2A receptor antagonist ZM241385 (Fig. 1C).
###end p 9
###begin p 10
###xml 379 380 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 489 491 485 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Effects of adenosine on histamine release from HLMC. (A) Effect of adenosine on constitutive histamine release from HLMC. The mean +/- SEM of four experiments is shown. (B) Effect of adenosine on IgE-dependent histamine release from HLMC following a maximal (1:1000 anti-IgE) or submaximal (1:30 000 anti-IgE) activation stimulus. The mean +/- SEM of four experiments is shown (*p<0.05 compared to control). (C) Inhibition of histamine release by adenosine is attenuated by the adenosine A2A receptor antagonist ZM241385. The mean +/- SEM of four experiments is shown. Donors are different from those in (A) and (B).
###end p 10
###begin title 11
###xml 31 33 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
Adenosine alone does not open KCa3.1 but opens an outwardly rectifying non-selective cation current
###end title 11
###begin p 12
###xml 22 24 22 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;7</sup>
###xml 230 232 230 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 268 270 268 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 315 317 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 324 326 324 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 385 392 385 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 432 434 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 926 928 926 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 1017 1018 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1261 1268 1253 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
###xml 1388 1389 1380 1381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1426 1427 1416 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1431 1432 1421 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1472 1473 1462 1463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1490 1491 1478 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1495 1496 1483 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1581 1583 1569 1571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1612 1613 1598 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1617 1618 1603 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1677 1678 1663 1664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1769 1770 1753 1754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1774 1775 1758 1759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1843 1844 1825 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1955 1957 1937 1939 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 2091 2093 2073 2075 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 2099 2101 2081 2083 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 2132 2134 2114 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 2164 2165 2144 2145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2169 2170 2149 2150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2189 2191 2169 2171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 2221 2222 2199 2200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2226 2227 2204 2205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2352 2354 2330 2332 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 2359 2361 2337 2339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
Adenosine at around 10-6 M has been reported to enhance IgE-dependent histamine release, although this was not the case in our hands. We therefore first examined the effects of adenosine alone in the concentration range 10-7 to 10-3 M to assess whether it might open KCa3.1, but it did not. However, adenosine at 10-4 and 10-3 M did open a novel strongly outwardly rectifying current (Fig. 2A). With an adenosine concentration of 10-3 M, this current appeared in 15/18 cells tested (n=6 donors) within 30 s of adding adenosine to the recording chamber, consistently reached maximal amplitude over the course of a few seconds, and typically "ran-down" completely over 20 s. This sequence could be re-initiated on further application of adenosine, but the transient nature of the current prevented detailed electrophysiological characterisation. In cells in which the outward current appeared, adenosine at a concentration of 10-3 M increased membrane current measured at +100 mV from 13.0+/-3.4 pA to 153.0+/-27.0 pA (n=15), with a positive shift in reversal potential from -14.4+/-3.4 mV to +5.9+/-9.8 mV. This current demonstrated instantaneous activation following voltage steps and increased slightly in amplitude over the course of a 100-millisecond pulse (Fig. 2B). There was no significant change in reversal potential or mean current at +100 mV when recording with extracellular Na+ methanesulphonate (162.2+/-62.1 pA, n=4, p=0.89) or N-methyl-D-glucamine (NMDG) Cl- (180+/-48.2 pA, n=7, p=0.61) rather than NaCl, and there was no change when recording with intracellular Cs2+ glutamate (142.0+/-36.3 pA, n=4, p=0.928) rather than KCl. However, replacing intracellular K+ with N-methyl-D-glucamine markedly reduced the outward current at +100 mV (31.7+/-6.0 pA, n=6, p=0.0013) but did not alter the reversal potential (Vm 5.8+/-3.5 mV, p=0.99). The ions carried by this current are therefore non-selective cations. Lastly, the selective adenosine A2A receptor agonist CGS21680 did not induce this outward current, and the current was still inducible in the presence of the selective A2A and A2B receptor antagonists ZM241385 33 (120.6+/-52.6 pA at +100 mV, n=5, p=0.56) and MRS1754 34 (160.2+/-66.9 pA at +100 mV, n=5, p=0.91), respectively. Taken together this suggests that induction of this non-selective cation current does not involve the A2A or A2B adenosine receptors.
###end p 12
###begin p 13
###xml 157 159 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
Adenosine activates an outwardly rectifying non-selective cation current in HLMC. (A) Current-voltage curve of the outwardly rectifying current induced by 10-3 M adenosine in a resting HLMC. (B) Raw current from the same cell as in (A) demonstrating instantaneous activation following voltage steps and slight accentuation during a 100 millisecond pulse. The voltage protocol is shown inset.
###end p 13
###begin title 14
###xml 18 20 18 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 57 59 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
Adenosine closes KCa3.1 in the presence of the specific KCa3.1 opener 1-EBIO
###end title 14
###begin p 15
###xml 43 45 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 218 220 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 238 240 238 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 322 324 322 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 363 365 363 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 435 437 435 437 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 513 515 512 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 559 561 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 614 616 612 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 667 669 665 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 670 671 668 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 671 673 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 708 709 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 765 767 762 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 798 800 795 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 801 802 798 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 838 840 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
We next examined whether adenosine closes KCa3.1 at concentrations that inhibit IgE-dependent degranulation. Because adenosine might potentially inhibit many cell activation pathways that could reduce cytosolic free Ca2+ and thus reduce KCa3.1 activity indirectly, we concentrated on studying the effects of adenosine on KCa3.1 currents that were induced by the KCa3.1 opener 1-ethyl-2-benzimidazolinone (1-EBIO). This compound opens KCa3.1 with a half-maximal value of about 30 muM for heterologously expressed KCa3.1, with a maximal effect at about 300 muM 35. The effects of 1-EBIO are relatively specific for KCa3.1, opening it by enhancing its sensitivity to [Ca2+]i35. Thus at 100 muM 1-EBIO, maximal K+ currents are achieved in the presence of 100 nM free Ca2+,which is below the resting [Ca2+]i of most cell types, including HLMC 15.
###end p 15
###begin p 16
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 77 79 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;5</sup>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 194 196 194 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 350 357 350 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3A</xref>
###xml 375 377 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 396 398 396 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 428 435 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4A</xref>
###xml 457 459 457 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 481 483 481 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 551 552 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 563 564 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 573 580 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4A</xref>
###xml 673 674 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 684 691 676 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4B</xref>
###xml 700 702 692 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 707 709 699 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 956 957 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 961 962 946 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1028 1029 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1038 1050 1019 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Figure 3B, C</xref>
###xml 1055 1060 1036 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">4C, D</xref>
###xml 1262 1264 1243 1245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
At concentrations of 10-6 M and below, adenosine had little or no effect on KCa3.1 currents that had been activated by 1-EBIO. However, addition of adenosine (10-5 to 10-3 M) to cells in which KCa3.1 had been activated by 1-EBIO produced a rapid dose-responsive inhibition of channel activity with an associated positive shift in membrane potential (Fig. 3A). Adenosine at 10-4 M suppressed the KCa3.1 current in >90% of cells (Fig. 4A). Thus addition of 10-4 M adenosine reduced KCa3.1 membrane current at +40 mV from 169.3+/-16.1 to 84.8+/-12.6 pA (n=49 cells, p<0.0001)(Fig. 4A), with a corresponding shift in reversal potential (Vm) from -61.0+/-1.3 to -35.1+/-4.0 mV (p<0.0001) (Fig. 4B). The IC50 of KCa3.1 by adenosine occurred at 30.9+/-12.7 muM (calculated from 5 cells). Importantly, the effect of adenosine was partially reversed within 1 min by removing it from the recording solution (current post-adenosine 90+/-41 pA, post-wash 131+/-39 pA, n=7, p=0.035; Vm post-adenosine -34.0+/-7.3 mV, post-wash -40+/-5.5 mV, p=0.095) (Figure 3B, C and 4C, D), indicating that non-specific "run-down" was not responsible for the effects seen. Because the outwardly rectifying current described above rapidly faded, this did not interfere with analysis of the KCa3.1 current.
###end p 16
###begin p 17
###xml 18 20 18 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 120 122 120 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 207 209 207 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
Adenosine closes KCa3.1 in HLMC. Current-voltage curves demonstrating (A) dose-dependent suppression of 1-EBIO-induced KCa3.1 current by adenosine and (B) reversibility of adenosine-mediated suppression of KCa3.1 following removal of adenosine (wash). (C) Raw currents from the same cell as illustrated in (B) above.
###end p 17
###begin p 18
###xml 16 18 16 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 85 87 85 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 123 125 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 139 140 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 247 249 247 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 323 325 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 551 553 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 628 629 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Suppression of KCa3.1 by adenosine is consistent and reversible. (A) Suppression of KCa3.1 current measured at +40 mV by 10-4 M adenosine (n=49 cells). (B) Shift in whole-cell current reversal potential (Vm) by 10-4 M adenosine (n=49 cells). (C) KCa3.1 current measured at +40 mV after addition of 1-EBIO, suppression by 10-4 M adenosine and then reversibility of suppression following removal of adenosine (wash) (n=7 cells). (D) Whole-cell current reversal potential (Vm) after the addition of 1-EBIO, a depolarising positive shift in response to 10-4 M adenosine and then reversibility following removal of adenosine (wash) (n=7 cells).
###end p 18
###begin title 19
###xml 1 3 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 48 50 48 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 60 62 60 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
KCa3.1 modulation by adenosine is mediated via A2A but not A2B receptors
###end title 19
###begin p 20
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 108 110 108 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 116 118 116 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 171 173 171 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 233 235 233 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 266 275 266 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5A&#8211;C</xref>
###xml 340 342 340 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 443 444 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 452 453 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 464 471 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5B</xref>
###xml 589 590 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 599 606 591 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5C</xref>
###xml 633 634 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 675 677 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 702 704 691 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 736 737 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 789 791 778 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 821 824 810 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 830 832 819 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 861 863 850 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 901 903 890 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 1042 1052 1031 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5D, E</xref>
###xml 1168 1170 1157 1159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 1226 1227 1215 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To confirm that the effects of adenosine were mediated via adenosine receptors, we examined the effects of A2A and A2B receptors agonists/antagonists. The suppression of KCa3.1 by adenosine was partially reversed by the competitive A2A receptor antagonist ZM241385 (Fig. 5A-C). Thus in experiments studying ZM241385 at a concentration of 10-6 M, current at +40 mV was 32.5+/-12.2 pA post-adenosine, increasing to 83.4+/-24.4 pA post-ZM241385 (p=0.048, n=11 cells)(Fig. 5B). There were parallel shifts in reversal potential (Vm post-adenosine -22.3+/-10.1 mV, post-ZM241385 -39.5+/-8.4 mV, p=0.007) (Fig. 5C). However, unlike the beta2-adrenoceptor inverse agonist ICI 118551 18, ZM241385 did not open KCa3.1 on its own (data not shown, n=10 cells tested). The effects of adenosine on the KCa3.1 current were not mediated via the A2B receptor, as the selective A2B receptor antagonist MRS1754 (up to 10-6 M) did not reverse the suppressive effects of adenosine (in fact there was a further small but significant decline in current amplitude) (Fig. 5D, E). When comparing the effects of ZM241385 with MRS1754 regarding their ability to reverse the adenosine-suppressed KCa3.1 current, there was a highly significant difference (p=0.008).
###end p 20
###begin p 21
###xml 77 79 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 146 148 146 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 185 187 185 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 223 225 223 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 299 301 299 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 379 381 379 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 412 413 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 549 551 549 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 615 617 615 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 648 649 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 666 668 666 668 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 742 744 742 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 812 814 812 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 844 845 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1044 1046 1044 1046 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1076 1077 1076 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Effects of adenosine receptor antagonists on adenosine-dependent closure of KCa3.1. (A) Current-voltage curve demonstrating the reversibility of KCa3.1 suppression of adenosine by the A2A receptor antagonist ZM241385. (B) KCa3.1 current measured at +40 mV after addition of 1-EBIO, suppression by 10-4 M adenosine and then reversibility of suppression following addition of the A2A receptor antagonist ZM241385 (n=11 cells). (C) Whole-cell current reversal potential (Vm) after the addition of 1-EBIO, a depolarising positive shift in response to 10-4 M adenosine, and then reversibility following addition of the A2A receptor antagonist ZM241385 (n=11 cells). (D) KCa3.1 current measured at +40 mV after addition of 1-EBIO, suppression by 10-4 M adenosine and then failure to reverse following addition of the A2B receptor antagonist MRS1754 (n=17 cells). (E) Whole-cell current reversal potential (Vm) after the addition of 1-EBIO, a depolarising positive shift in response to adenosine and then failure to reverse following addition of the A2B receptor antagonist MRS1754 (n=17 cells).
###end p 21
###begin p 22
###xml 27 29 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 66 68 66 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 96 98 96 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 219 225 219 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6</xref>
###xml 252 254 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 280 282 280 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 334 335 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 343 344 339 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
In further support of the A2A adenosine receptor coupling to the KCa3.1 channel, the selective A2A receptor agonist CGS21680 mimicked the effects of native adenosine in a dose-dependent and partially reversible manner (Fig. 6). At a concentration of 10-6 M, CGS21680 reduced the KCa3.1 current from 118.8+/-24.1 pA to 97.4+/-21.8 pA (p=0.007, n=9).
###end p 22
###begin p 23
###xml 28 30 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 52 54 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 164 166 164 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 186 188 186 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
The effect of an adenosine A2A receptor agonist on KCa3.1 currents in HLMC. (A) Current-voltage curve demonstrating dose-dependent suppression of a 1-EBIO-induced KCa3.1 current by the A2A receptor agonist CGS21680 and (B) reversibility of this suppression following its removal (wash).
###end p 23
###begin p 24
###xml 65 67 65 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 88 90 88 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 193 195 193 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 361 363 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;4</sup>
###xml 424 425 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 498 499 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 605 606 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 633 634 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 642 648 626 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7</xref>
Lastly, we confirmed that the adenosine-dependent regulation of KCa3.1 was relevant to KCa3.1 channels that had been opened by anti-IgE-dependent activation. Anti-IgE (1:1000 dilution) opened KCa3.1 in 6/6 cells tested (baseline current at +40 mV 17.5+/-7.3 pA, baseline Vm -34.5+/-8.0 mV; post anti-IgE current 81.5+/-18.0 pA, Vm -62.3+/-2.5 mV). Adenosine (10-4 M) suppressed the current to 49.3+/-12.6 pA post-adenosine (p=0.007) and produced an associated positive shift in Vm (-49.2+/-6.5 mV, p=0.046). This suppressive effect of adenosine was partially reversed by ZM241385 (current 75.6+/-19.8 pA, p=0.050; Vm -58.5+/-4.8 mV, p=0.020)(Fig. 7).
###end p 24
###begin p 25
###xml 28 30 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 137 139 137 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 301 303 301 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
The effect of adenosine on KCa3.1 currents elicited by anti-IgE-dependent mast cell activation. Data from a representative HLMC showing KCa3.1 current opening following anti-IgE-dependent activation, suppression of this by adenosine and reversal of the adenosine-induced suppression by the adenosine A2A receptor antagonist ZM241385.
###end p 25
###begin title 26
Adenosine inhibits HLMC migration
###end title 26
###begin p 27
###xml 157 160 146 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 250 252 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 269 271 258 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 336 338 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 485 486 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 490 491 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 575 577 562 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 596 603 580 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig08">Fig. 8A</xref>
###xml 674 676 658 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 723 725 707 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 758 760 742 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 765 766 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 770 771 754 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 780 787 764 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig08">Fig. 8B</xref>
Conditioned medium from asthmatic airway smooth muscle that has been activated with TNF-alpha, IFN-gamma and IL-1beta mediates HLMC chemotaxis predominantly via the CXCL10/CXCR3 pathway, with additional contributions from ligands for CXCR1 and CXCR3 36. Inhibition of KCa3.1 by channel blockers markedly suppresses this HLMC chemotaxis 17. Migration of HLMC using conditioned medium from asthmatic airway smooth muscle was 2.0+/-0.7-fold higher than in the presence of control medium (n=5, p=0.029), and this was almost completely abrogated by adenosine, with a calculated IC50 of 2.5+/-0.8 muM (Fig. 8A). This inhibitory effect of adenosine on HLMC migration utilised the A2A adenosine receptor, as it was blocked by the A2A receptor antagonist ZM241385 (10-6 M) (n=3, p=0.010) (Fig. 8B).
###end p 27
###begin p 28
###xml 215 216 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Inhibition of HLMC chemotaxis by adenosine. (A) Conditioned medium from asthmatic airway smooth muscle (ASM) was used as the chemotactic stimulus. Data represents the mean +/- SEM from five individual HLMC donors (*p<0.005). (B) Inhibition of HLMC migration by adenosine is prevented by the A2A receptor antagonist ZM241385. Data represents the mean +/- SEM from three individual HLMC donors.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 205 207 205 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 212 213 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 231 237 231 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 247 249 243 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 378 380 374 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 385 386 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 409 411 405 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 443 445 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 502 504 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 602 604 598 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
In this study we have tested the novel hypothesis that modulation of HLMC activation by adenosine interferes with ion channel function in these cells. We show for the first time that adenosine closes the KCa3.1 K+ channel via the Galphas-coupled A2A adenosine receptor and that, as predicted from this effect, adenosine markedly attenuates HLMC migration. Since opening of the KCa3.1 K+ channel potentiates Ca2+ influx and histamine secretion 14 and its blockade almost abolishes chemotactic responses 17, the ability of adenosine to close this channel provides a potential mechanism directly linking A2A receptor engagement with diminished secretion and migration.
###end p 30
###begin p 31
###xml 18 20 18 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 214 216 214 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 316 318 316 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 372 374 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 432 434 432 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 588 590 588 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 733 735 733 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 790 792 790 792 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 867 869 867 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 898 901 898 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 907 909 907 909 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Adenosine closed KCa3.1 following IgE-dependent activation, but it was possible that this effect might occur indirectly through the perturbation of complex intracellular signalling pathways. We therefore used the KCa3.1 opener 1-EBIO to activate the channel rather than IgE-dependent activation. Since 1-EBIO opens KCa3.1 in resting cells by increasing its affinity for Ca2+35, it is particularly interesting that adenosine closes KCa3.1 under these conditions. This effect of adenosine was reversed both by removing it from the recording solution and by the addition of the competitive A2A adenosine receptor antagonist ZM241385, indicating a receptor-mediated mechanism. Since the effects of adenosine were not antagonised by the A2B receptor antagonist MRS1754 but were mimicked by the A2A receptor agonist CGS21680, we have firm evidence that the suppression of KCa3.1 by adenosine is mediated via the A2A adenosine receptor.
###end p 31
###begin p 32
###xml 35 37 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 122 128 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 141 142 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 156 158 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 183 185 176 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 204 205 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 234 236 224 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 323 325 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 406 412 396 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;s</sub>
###xml 512 513 488 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 543 545 519 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 733 735 709 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 750 752 726 728 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
The ability of adenosine to close KCa3.1 is in keeping with our previous observations that this channel is closed by the Galphas-coupled beta2-adrenoceptor 18. These effects of both A2A adenosine and beta2-adrenoceptor activation on KCa3.1 are not mimicked by cAMP analogues or the activator of adenylate cyclase forskolin 18, indicating that the most likely mechanism is membrane-delimited involving the Galphas or betagamma subunits of these GPCR. This is further suggested by the fact that adenosine (and beta2-receptor agonists) modulate KCa3.1 in the whole-cell configuration of patch-clamp recording. This mode of recording dialyses the cell and depletes soluble intracellular second messengers, indicating that the adenosine A2A receptor and KCa3.1 channel are likely to be coupled tightly in a membrane-restricted signalplex.
###end p 32
###begin p 33
###xml 77 78 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 428 430 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 432 434 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 478 480 475 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 509 511 506 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 537 539 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 578 580 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 628 630 625 627 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 710 712 707 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Several molecules that attenuate HLMC secretion, including adenosine and beta2-adrenoceptor agonists, increase intracellular cAMP. It is this increase in intracellular cAMP that has been thought to couple to inhibition of secretion, but there is no mechanism to explain this. However, the exclusive role of cAMP in the inhibition of mast cell degranulation and promotion of smooth muscle relaxation has recently been challenged 37, 38. We have shown previously that opening of KCa3.1 enhances IgE-dependent Ca2+ influx and degranulation 15 and that its blockade attenuates this 14. Thus the demonstration that adenosine closes KCa3.1 provides for the first time a clearly defined mechanism by which adenosine A2A receptor stimulation can be linked to attenuated secretion.
###end p 33
###begin p 34
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 480 482 480 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 689 691 689 691 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 833 835 833 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 870 872 857 859 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 879 881 866 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 937 939 911 913 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 996 1002 957 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 1111 1113 1072 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 1145 1147 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 1149 1151 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 1198 1200 1159 1161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 1278 1280 1239 1241 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 1384 1386 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 1388 1390 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 1470 1472 1431 1433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 1536 1538 1497 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 1600 1606 1561 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 1608 1610 1569 1571 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 1931 1933 1886 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
The migration and re-location of mast cells within tissues is important for their effector function in a number of diseases 10, 39, 40. For example in asthma, the role of mast cells in the disordered airway physiology is facilitated by their migration into the airway epithelium 41, submucosal glands 11 and airway smooth muscle 10. Inhibition of their migration and subsequent microlocalisation within these structures is therefore an attractive therapeutic target. Blockade of KCa3.1 markedly inhibits HLMC migration in response to a number of diverse chemotactic stimuli, including conditioned medium from activated asthmatic airway smooth muscle 17. The ability of adenosine to close KCa3.1 suggested it should also inhibit HLMC migration, which was indeed the case. Adenosine was slightly more potent at inhibiting migration (IC50 approximately3 muM) than closing KCa3.1 (IC50 approximately31 muM) or inhibiting mediator release (IC50 approximately74 muM). These results regarding migration versus degranulation are consistent with the observation that HLMC migration is also far more sensitive to direct KCa3.1 blockade than degranulation 14, 17. Migration appears particularly sensitive to KCa3.1 blockade, because even a partial block markedly inhibits oscillations in KCa activity, which in turn prevents the changes in cell volume that are required for migration to proceed 42, 43. This is further supported by the observation that in addition to blocking of KCa3.1, permanently opening it with 1-EBIO also inhibits migration 44. However, the relative sensitivity of migration to adenosine versus KCa3.1 closure might also suggest that the effects of adenosine on migration operate through additional mechanisms, such as generation of cAMP. However, the experimental conditions are also likely to account for some of this difference. This is because we can only reliably patch-clamp HLMC at temperatures up to 27degreesC 14, which will likely slow down the kinetics and magnitude of any agonist effect, and we have also recorded currents in the whole-cell configuration, which dialyses the cell, resulting in the loss of potentially important signalling components. In contrast, cell migration and mediator release assays are performed in intact cells at 37degreesC.
###end p 34
###begin p 35
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 573 575 573 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 633 635 633 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 769 770 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 793 795 793 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 825 827 825 827 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 1095 1097 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">47</xref>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
###xml 1067 1072 <span type="species:ncbi:9606">human</span>
Previous studies have suggested that at lower concentrations (approximately 10-6 M), adenosine actually promotes mediator release from human mast cells 23-27. However, the magnitude of this effect and the concentrations of adenosine required to produce it have been highly varied 23-27, 29, and a recent study investigating cord blood-derived human mast cells did not find any potentiating effect 30. Adenosine did not potentiate degranulation from HLMC in our hands, which is in keeping with a failure to detect any modulation of ion channel activity, such as opening of KCa3.1 either directly or indirectly through initiation of Ca2+ influx, which might be predicted to enhance secretion. Interestingly, in rodent mast cells, adenosine opens an outwardly rectifying K+ channel that is not Ca2+-activated, is distinct from KCa3.1 and has been proposed to account for the ability of adenosine to enhance mediator release in these cells 45, 46. We did not see this channel in HLMC, which is yet another example of the important heterogeneity evident in the biology of human and rodent mast cells 47.
###end p 35
###begin p 36
###xml 31 33 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 286 288 286 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 294 296 294 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 488 490 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
In addition to its effects on KCa3.1, adenosine at relatively high concentrations opened a novel and transient outwardly rectifying ion channel that was indirectly demonstrated to carry non-selective cations. Interestingly, this current still appeared in the presence of the adenosine A2A and A2B receptor antagonists, suggesting that it is mediated through another pathway. Because this outwardly rectifying current depolarises the cells (and would therefore be predicted to attenuate Ca2+ influx) and occurs at concentrations of adenosine that attenuate degranulation, it is possible that this channel also inhibits mast cell mediator release. The transient nature of this current might be due to "run-down" caused by the depletion of intracellular second messengers induced by whole-cell recording, but we believe that this is unlikely due to the very rapid nature by which the current diminishes. However, it will be important that this is analysed in more detail using the perforated patch mode of recording.
###end p 36
###begin p 37
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 183 186 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 192 194 192 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 320 322 320 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 466 468 466 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 559 561 559 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 653 655 653 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 683 685 683 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 765 767 765 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
In vivo, adenosine induces airway narrowing in asthmatic subjects, with evidence that this results from mast cell degranulation 20, 21. This effect is thought to be mediated directly via the A2B adenosine receptor on mast cells, although this is not proven, and might also involve indirect mechanisms 28, 32. Adenosine A2B receptor antagonists are therefore being considered as novel therapies for asthma. An alternative strategy is to target the anti-inflammatory A2A receptor with specific agonists delivered locally to the airway 48, 49. Drugs that block KCa3.1 are also in development as anti-inflammatory treatments 13. Our demonstration that the A2A adenosine receptor closes KCa3.1 in HLMC therefore provides further support for the development of specific A2A adenosine receptor agonists for the treatment of mast cell-mediated disease.
###end p 37
###begin title 38
Materials and methods
###end title 38
###begin title 39
Reagents
###end title 39
###begin p 40
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 406 407 406 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 92 96 <span type="species:ncbi:9925">goat</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 313 318 <span type="species:ncbi:10090">mouse</span>
###xml 386 391 <span type="species:ncbi:9940">sheep</span>
###xml 397 402 <span type="species:ncbi:10090">mouse</span>
We used the following reagents: stem cell factor (SCF), IL-6 and IL-10 (R&D, Abingdon, UK); goat polyclonal anti-human IgE, adenosine, CGS21680, ZM241385, MRS1754 (Sigma, Poole, Dorset, UK); 1-ethyl-2-benzimidazolinone (1-EBIO) (Tocris, Avonmouth, UK); human myeloma IgE (Calbiochem-Novabiochem, Nottingham, UK); mouse IgG1 mAb YB5B8 (anti-CD117) (Cambridge Bioscience, Cambridge, UK); sheep anti-mouse IgG1 Dynabeads (Dynal, Wirral, UK); Dulbecco's Modified Essential Medium (DMEM)/glutamax/Hepes, antibiotic/antimycotic solution, MEM nonessential amino acids and FCS (Life Technologies, Paisley, Scotland, UK).
###end p 40
###begin title 41
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human mast cell purification and culture
###end title 41
###begin p 42
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
All human subjects gave written informed consent, and the study was approved by the Leicestershire Research Ethics Committee. HLMC were dispersed and purified from macroscopically normal lung (n=11 donors) obtained within 1 h of resection for lung cancer using immunomagnetic affinity selection as described previously 50. Final mast cell purity was >99%, and viability was >97%. HLMC were cultured in DMEM/glutamax/Hepes containing antibiotic/antimycotic solution, nonessential amino acids, 10% FCS, 100 ng/mL SCF, 50 ng/mL IL-6 and 10 ng/mL IL-10 for up to 10 wks as described previously 15, 51.
###end p 42
###begin title 43
HLMC activation
###end title 43
###begin p 44
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 433 435 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 675 677 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 285 289 <span type="species:ncbi:9925">goat</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
For analysis of histamine release, 1 x 104 mast cells were warmed to 37degreesC in triplicate in 50 muL DMEM. Adenosine (+/- ZM241385 or DMSO control) at 4x the final concentration in 25 muL DMEM was added just prior to addition of 25 muL DMEM containing 4x the final concentration of goat polyclonal anti-human IgE (1:1000 final dilution gives maximal histamine release, 1:30 000 final dilution gives sub-maximal histamine release) 15. After 30 min incubation at 37degreesC, the cells were centrifuged at 250 x g for 4 min, the supernatant decanted and control cell pellets lysed in sterile deionised water for measurement of total histamine content as described previously 50. The final DMSO concentration was 0.1%.
###end p 44
###begin title 45
Electrophysiology
###end title 45
###begin p 46
###xml 61 63 61 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 328 329 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 351 352 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 454 455 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 466 467 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The whole-cell variant of the patch-clamp technique was used 14, 52. Patch pipettes were made from borosilicate fiber-containing glass (Clark Electromedical Instruments, Reading, UK), and their tips were heat-polished, typically resulting in resistances of 4-6 Mohm. The standard pipette solution contained 140 mM KCl, 2 mM MgCl2, 10 mM Hepes, 2 mM Na+-ATP and 0.1 mM GTP, pH 7.3. The standard external solution contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2 and 10 mM Hepes, pH 7.3. For recording, mast cells were placed in 35-mm dishes containing standard external solution. Whole-cell currents were recorded using an Axoclamp 200 A amplifier (Axon Instruments, Foster City, CA, USA), and currents were evoked by applying voltage commands to a range of potentials in 10 mV steps from a holding potential of -20 mV. The currents were digitized (sampled at a frequency of 10 kHz), stored on computer and subsequently analyzed using pClamp software (Axon Instruments). Capacitance transients were minimized using the capacitance neutralization circuits on the amplifier. Correction for series resistance was not routinely applied. Experiments were performed at 27degreesC, with the temperature controlled by a Peltier device. Experiments were performed with a perfusion system (Automate Scientific, San Francisco, CA) to allow solution changes, although drugs were added directly to the recording chamber.
###end p 46
###begin title 47
HLMC chemotaxis
###end title 47
###begin p 48
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 318 320 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 460 462 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;6</sup>
###xml 465 467 454 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;3</sup>
###xml 481 482 470 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 849 851 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 853 855 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
HLMC chemotaxis assays were performed using the Transwell system (BD Biosciences, Oxford, UK) with 24-well plates as described previously 17, 36. Conditioned medium from asthmatic airway smooth muscle that had been activated with TNF-alpha, IL-1beta and IFN-gamma was placed in the lower wells as described previously 36, with appropriate cytokine-containing medium in the negative control. Adenosine was added to the bottom wells in the concentration range 10-6-10-3 M, and 1 x 105 HLMC in 100 muL were added to the top well. After incubating the cells for 3 h at 37degreesC, we counted the number of HLMC in the bottom well using Kimura stain in a haemocytometer. HLMC migration was calculated as the fold increase of migrated cells in the test wells compared to the negative control (no chemoattractant in the lower well) as described previously 17, 36.
###end p 48
###begin title 49
Data presentation and statistical analysis
###end title 49
###begin p 50
###xml 144 146 142 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t-</italic>
Data are expressed as mean +/- SEM unless otherwise stated. Differences between groups of data were explored using Student's paired or unpaired t-test (two-tailed) as appropriate.
###end p 50
###begin p 51
This work was supported by the Wellcome Trust (grant number 076264). We thank Amanda Sutcliffe for technical support.
###end p 51
###begin article-title 52
###xml 20 25 <span type="species:ncbi:9606">human</span>
Immunopathology and human mast cell cytokines
###end article-title 52
###begin article-title 53
The role of the mast cell in asthma: a reassessment
###end article-title 53
###begin article-title 54
The role of the mast cell in the pathophysiology of asthma
###end article-title 54
###begin article-title 55
###xml 55 60 <span type="species:ncbi:9606">human</span>
NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells?
###end article-title 55
###begin article-title 56
Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses
###end article-title 56
###begin article-title 57
###xml 120 125 <span type="species:ncbi:9606">human</span>
Cutting edge: Distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells
###end article-title 57
###begin article-title 58
Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3
###end article-title 58
###begin article-title 59
Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity
###end article-title 59
###begin article-title 60
Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE
###end article-title 60
###begin article-title 61
Mast cell infiltration of airway smooth muscle in asthma
###end article-title 61
###begin article-title 62
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma
###end article-title 62
###begin article-title 63
Mast cell ion channels
###end article-title 63
###begin article-title 64
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
K+ channels as targets for specific immunomodulation
###end article-title 64
###begin article-title 65
###xml 49 54 <span type="species:ncbi:9606">human</span>
Resting and activation-dependent ion channels in human mast cells
###end article-title 65
###begin article-title 66
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 17 19 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 66 71 <span type="species:ncbi:9606">human</span>
The K+ channel IKCa1 potentiates Ca2+ influx and degranulation in human lung mast cells
###end article-title 66
###begin article-title 67
Depletion of intracellular calcium stores activates a calcium current in mast cells
###end article-title 67
###begin article-title 68
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 48 53 <span type="species:ncbi:9606">human</span>
Functional KCa3. 1 K+ channels are required for human lung mast cell migration
###end article-title 68
###begin article-title 69
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 50 52 50 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca</sub>
###xml 57 62 <span type="species:ncbi:9606">human</span>
Beta2-adrenoceptor regulation of the K+ channel IKCa1 in human mast cells
###end article-title 69
###begin article-title 70
Adenosine in bronchoalveolar lavage fluid in asthma
###end article-title 70
###begin article-title 71
Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease
###end article-title 71
###begin article-title 72
The Quintiles Prize Lecture 2004: The identification of the adenosine A2B receptor as a novel therapeutic target in asthma
###end article-title 72
###begin article-title 73
Adenosine A2B receptors: a novel therapeutic target in asthma?
###end article-title 73
###begin article-title 74
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments
###end article-title 74
###begin article-title 75
###xml 72 77 <span type="species:ncbi:9606">human</span>
Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism
###end article-title 75
###begin article-title 76
###xml 27 32 <span type="species:ncbi:9606">human</span>
Differential regulation of human basophil and lung mast cell function by adenosine
###end article-title 76
###begin article-title 77
###xml 44 49 <span type="species:ncbi:9606">human</span>
Adenosine potentiates mediator release from human lung mast cells
###end article-title 77
###begin article-title 78
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human lung mast cells: purification and characterization
###end article-title 78
###begin article-title 79
###xml 14 19 <span type="species:ncbi:9606">human</span>
Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)
###end article-title 79
###begin article-title 80
###xml 57 62 <span type="species:ncbi:9606">human</span>
ATP modulates anti-IgE-induced release of histamine from human lung mast cells
###end article-title 80
###begin article-title 81
###xml 51 56 <span type="species:ncbi:9606">human</span>
Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc[epsilon]RI
###end article-title 81
###begin article-title 82
Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma
###end article-title 82
###begin article-title 83
###xml 63 74 <span type="species:ncbi:10141">guinea pigs</span>
Mechanism of adenosine-induced airways obstruction in allergic guinea pigs
###end article-title 83
###begin article-title 84
###xml 30 39 30 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">[1, 2, 4]</sup>
###xml 55 64 55 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">[1, 3, 5]</sup>
125I-4-(2-[7-amino-2-[2-furyl][1, 2, 4]triazolo[2, 3-a][1, 3, 5] triazin-5- yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor
###end article-title 84
###begin article-title 85
[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors
###end article-title 85
###begin article-title 86
###xml 18 23 <span type="species:ncbi:9606">human</span>
Activation of the human intermediate-conductance Ca(2+)-activated K(+) channel by 1-ethyl-2-benzimidazolinone is strongly Ca(2+)-dependent
###end article-title 86
###begin article-title 87
###xml 31 36 <span type="species:ncbi:9606">human</span>
The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle
###end article-title 87
###begin article-title 88
###xml 124 129 <span type="species:ncbi:9606">human</span>
Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells
###end article-title 88
###begin article-title 89
Beta-adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms
###end article-title 89
###begin article-title 90
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders
###end article-title 90
###begin article-title 91
Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression
###end article-title 91
###begin article-title 92
###xml 108 113 <span type="species:ncbi:9606">human</span>
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines
###end article-title 92
###begin article-title 93
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Oscillating activity of a Ca(2+)-sensitive K+ channel. A prerequisite for migration of transformed Madin-Darby canine kidney focus cells
###end article-title 93
###begin article-title 94
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Extracellular detection of K+ release during migration of transformed Madin-Darby canine kidney cells
###end article-title 94
###begin article-title 95
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Migration of transformed renal epithelial cells is regulated by K+ channel modulation of actin cytoskeleton and cell volume
###end article-title 95
###begin article-title 96
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Activation of mast cell K+ channels through multiple G protein-linked receptors
###end article-title 96
###begin article-title 97
Selective expression of potassium channels during mast cell differentiation
###end article-title 97
###begin article-title 98
Functional mast cell heterogeneity
###end article-title 98
###begin article-title 99
Adenosine receptor ligands as potential therapeutics in asthma
###end article-title 99
###begin article-title 100
###xml 106 109 <span type="species:ncbi:10116">rat</span>
Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat
###end article-title 100
###begin article-title 101
###xml 12 17 <span type="species:ncbi:9606">human</span>
Adhesion of human lung mast cells to bronchial epithelium: evidence for a novel carbohydrate-mediated mechanism
###end article-title 101
###begin article-title 102
###xml 14 19 <span type="species:ncbi:9606">human</span>
Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation
###end article-title 102
###begin article-title 103
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches
###end article-title 103
###begin title 104
Abbreviations:
###end title 104
###begin p 105
1-ethyl-2-benzimidazolinone
###end p 105
###begin p 106
G protein-coupled receptor
###end p 106
###begin p 107
###xml 0 5 <span type="species:ncbi:9606">human</span>
human lung mast cell
###end p 107

